This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Biogen Ma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Joseph Palte: Patent Activity in Multiple Sclerosis Treatment
Introduction
Michael Joseph Palte is an inventor associated with Melrose, Massachusetts, and Biogen Inc. His listed patent concerns combination therapies for autoimmune diseases, including multiple sclerosis.
Latest Patents
Palte is credited with 1 patent: “Combination Treatment Methods of Multiple Sclerosis.” The disclosure describes treating autoimmune diseases by administering a Bruton’s tyrosine kinase (BTK) inhibitor together with a fumaric acid ester (FAE). It identifies multiple sclerosis as one potential application and also discusses conditions such as lupus, rheumatoid arthritis, pemphigus vulgaris, neuromyelitis optica, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, anti-NMDA receptor encephalitis, and Sjögren’s disease.
Career Highlights
Palte’s listed patent activity is focused on combination approaches to autoimmune disease treatment. The patent describes pairing two therapeutic agents as a method for addressing multiple sclerosis and other immune-related conditions.
Collaborations
The provided information lists Brian T. Hopkins and Michael Christian Mingueneau as Palte’s coworkers. Their names are associated with his professional context, though specific roles in the patent are not provided.
Conclusion
Michael Joseph Palte’s recorded invention explores combining a BTK inhibitor with a fumaric acid ester to treat multiple sclerosis and other autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile